May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China
Xin Chen,Li‐Ping Zhang,Xiao‐Long Wang,Ning‐Ru Zhang,Jing Yu,Li‐Ying Xu,Tong‐She Li,Hong Luan,Juan Zhang,Ya‐Min Hu,Dan Liu,Qi‐Dong Zheng,Yan Li,Ji‐Guang Wang
DOI: https://doi.org/10.1111/jch.14919
2024-10-24
Journal of Clinical Hypertension
Abstract:We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID‐19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1‐min interval in the sitting position, using a validated automated BP monitor (Omron HEM‐7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p
peripheral vascular disease